| 发明名称 |
UNIT DOSAGE FORM COMPRISING EMTRICITABINE, TENOFOVIR, DARUNAVIR AND RITONAVIR |
| 摘要 |
The present invention relates to an oral unit dosage form comprising Emtricitabine, Tenofovir, Darunavir and Ritonavir and a monolithic tablet comprising Darunavir and Ritonavir and their use to treat HIV infection. |
| 申请公布号 |
EP3129009(A1) |
申请公布日期 |
2017.02.15 |
| 申请号 |
EP20150724361 |
申请日期 |
2015.04.07 |
| 申请人 |
Teva Pharmaceutical Industries Ltd |
发明人 |
SHAHAR, Nitzan;HARONSKY, Elina;HRAKOVSKY, Julia |
| 分类号 |
A61K9/20;A61K9/24;A61K31/34;A61K31/427;A61K31/513;A61K31/675;A61P31/18 |
主分类号 |
A61K9/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
